Related Experiment Video
Updated: Nov 27, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Overview of Plasma and Platelet Transfusions in Critically Ill Children
Stacie Kahn1, Madhuradhar Chegondi2, Marianne E Nellis3
1Division of Pediatric Critical Care Medicine, NewYork-Presbyterian, Morgan Stanley Children's Hospital, New York, NY, United States.
Insights
Plasma and platelet transfusions are common in critically ill children, but clear indications for use are lacking. This review examines current evidence, risks, and benefits for pediatric intensive care hemostasis.
Area of Science:
- Pediatric Critical Care Medicine
- Transfusion Medicine
- Pediatric Hematology
Background:
- Critically ill children often receive plasma and platelet transfusions.
- Indications for these transfusions in pediatric intensive care are not well-defined.
- Practices vary significantly among healthcare providers and institutions.
Purpose of the Study:
- To review current evidence on plasma and platelet transfusions for hemostasis in pediatric intensive care.
- To describe product composition, epidemiology, and indications for use.
- To discuss potential risks, benefits, knowledge gaps, and future research.
Main Methods:
- Literature review of existing evidence.
- Analysis of product composition and epidemiological data.
- Discussion of clinical indications, risks, and benefits.
Main Results:
- Current evidence on transfusion indications in pediatric intensive care is limited.
- Plasma and platelet transfusions carry potential risks and benefits.
- Significant knowledge gaps exist regarding optimal transfusion strategies.
Conclusions:
- Further research is needed to establish clear transfusion guidelines for critically ill children.
- Optimizing transfusion practices can improve hemostasis and patient outcomes.
- Evidence-based recommendations are crucial for consistent care.
Abstract:
Critically ill children are a unique population who frequently receive plasma and platelet transfusions for both active bleeding and mitigation of bleeding risk. While these products are frequently administered, transfusion indications in this population remain unclear, and practice varies across institutions and providers. In this manuscript, we will outline the current evidence regarding plasma and platelet transfusions for hemostasis in the pediatric intensive care setting. For both products, we will describe the product composition, epidemiology, and product indications and discuss the potential risks and benefits involved with the transfusion. We will also discuss knowledge gaps and future areas of research.
More Related Videos
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

